Renal cell carcinoma future or investigational therapies: Difference between revisions
Created page with "{{CMG}} {{Renal cell carcinoma}} ==Overview== '''Renal cell carcinoma''' is the most common form of '''kidney cancer''' arising from the renal tubule. It is the most comm..." |
No edit summary |
||
| Line 5: | Line 5: | ||
'''Renal cell carcinoma''' is the most common form of '''kidney cancer''' arising from the [[renal tubule]]. It is the most common type of [[kidney]] [[cancer]] in adults. | '''Renal cell carcinoma''' is the most common form of '''kidney cancer''' arising from the [[renal tubule]]. It is the most common type of [[kidney]] [[cancer]] in adults. | ||
Other associated genes include TRC8, OGG1, [[HNF1A]], [[HNF1B]], [[TFE3]], RCCP3, and RCC17. | Other associated genes include TRC8, OGG1, [[HNF1A]], [[HNF1B]], [[TFE3]], RCCP3, and RCC17. | ||
==Future or Investigational Therapies== | |||
===Vaccine=== | |||
In November 2006, it was announced that a [[vaccine]] had been developed and tested with very promising results.(See [http://www.dailymail.co.uk/pages/live/articles/news/news.html?in_article_id=416006&in_page_id=1770]) The new vaccine, called [[TroVax]], works by harnessing the patient's own immune system to fight the disease. Oxford BioMedica[http://www.oxfordbiomedica.co.uk/]. Further vaccine trials are underway. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 20:44, 27 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Renal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal cell carcinoma future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Renal cell carcinoma future or investigational therapies |
|
FDA on Renal cell carcinoma future or investigational therapies |
|
CDC on Renal cell carcinoma future or investigational therapies |
|
Renal cell carcinoma future or investigational therapies in the news |
|
Blogs on Renal cell carcinoma future or investigational therapies |
|
Risk calculators and risk factors for Renal cell carcinoma future or investigational therapies |
Overview
Renal cell carcinoma is the most common form of kidney cancer arising from the renal tubule. It is the most common type of kidney cancer in adults. Other associated genes include TRC8, OGG1, HNF1A, HNF1B, TFE3, RCCP3, and RCC17.
Future or Investigational Therapies
Vaccine
In November 2006, it was announced that a vaccine had been developed and tested with very promising results.(See [2]) The new vaccine, called TroVax, works by harnessing the patient's own immune system to fight the disease. Oxford BioMedica[3]. Further vaccine trials are underway.